6 completed, 4 unknown, 1 not yet recruiting. 5 Phase 3, 2 Phase 2, 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
| Phase 2 | 2 | Unknown 2 |
| Phase 4 | 2 | Completed 1, Not yet recruiting 1 |
| Not applicable | 1 | Unknown 1 |
Follow rHuEPO: new trials by email Literature Review of rHuEPO trials Research Report on rHuEPO
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients Roxadustat, Recombinant human erythropoietin (EPO) - Sarcopenia, Anemia Associated With Chronic Kidney Disease (CKD) | Phase 4 | Not yet recruiting | Tianjin Medical University General Hospital | 60 | 2025-09-10 | 2025-09-09 |
| A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD) Roxadustat, rHuEPO - Anemia of Chronic Kidney Disease | Phase 4 | Completed | AstraZeneca | 25 | 2021-02-22 | 2024-04-22 |
| A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis RD01, Recombinant Human Erythropoiesis Injection (CHO cell), placebo - Patient of Anemia in Chronic Renal Failure With Hemodialysis | Phase 2 | Unknown | Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd | 105 | 2020-03-01 | 2020-01-18 |
| Study of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis Recombinant Human Erythropoiesis Injection (CHO cell), Recombinant Erythropoiesis Stimulating Protein Injection(CHO cell) - Chronic Renal Failure With Hemodialysis | Phase 2 | Unknown | Shenyang Sunshine Pharmaceutical Co., LTD. | 150 | 2019-06-24 | 2020-03-09 |
| Erythropoietin And/Or Iron Sucrose For Perioperative Anemia Management In Hip and Knee Arthroplasty rHuEPO, Iron sucrose - Anemia, Iron Deficiency | Unknown | Peking Union Medical College Hospital | 780 | 2019-04-24 | 2019-04-25 | |
| Effect of Recombinant Human EPO on the Postoperative Neurologic Outcome in Pediatric Moyamoya Patients erythropoietin, Normal saline - Moyamoya Disease, Pediatrics | Not applicable | Unknown | Seoul National University Hospital | 60 | 2019-04-08 | 2023-11-22 |
| Clinical Study of R744 to Hemodialysis Patients R744, rHuEPO, R744 placebo - Hemodialysis Patients | Phase 3 | Completed | Chugai Pharmaceutical | 134 | 2007-06-01 | 2009-02-02 |
| Recombinant Human Erythropoietin Compared to Autologous Pre-Donation Prior to Scoliosis Surgery in Children. rHuEpo - Scoliosis | Phase 3 | Completed | University of British Columbia | 20 | 2004-10-01 | 2008-09-25 |
| Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy rHuEPO, Darbepoetin alfa - Cancer, Non-Myeloid Malignancies | Phase 3 | Completed | Amgen | 718 | 2003-02-01 | 2008-02-28 |
| Anemia in Patients With a Non-Myeloid Malignancy Darbepoetin alfa, rHuEPO - Neoplasms, Anemia | Phase 3 | Completed | Amgen | 707 | 2002-01-01 | 2008-09-15 |
| NESP Pediatric Study darbepoetin alfa, rHuEPO - Pre-dialysis, End Stage Renal Disease | Phase 3 | Completed | Amgen | 120 | 2000-08-01 | 2013-05-08 |
Anemia (4) · Neoplasms (2) · Anemia, Iron-Deficiency (1) · Cerebrovascular Disorders (1) · Hemorrhage (1) · Kidney Failure, Chronic (1) · Moyamoya Disease (1) · Renal Insufficiency, Chronic (1) · Sarcopenia (1) · Scoliosis (1)
Amgen (3) · AstraZeneca (1) · Chugai Pharmaceutical (1) · Peking Union Medical College Hospital (1) · Seoul National University Hospital (1) · Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd (1) · Shenyang Sunshine Pharmaceutical Co., LTD. (1) · Tianjin Medical University General Hospital (1) · University of British Columbia (1)
China (4) · Canada (1) · Japan (1) · South Korea (1)
Eleanor Reimer, MD (1) · Li Xuemei (1) · Takanori Baba (1) · Wei Wang, PhD (1)
PMID 16724235, PMID 35806119, PMID 36364144, PMID 37812446, PMID 38280066, PMID 38333911